Table 2 Lesion characteristics distribution among the studied groups.

From: Intralesional injection of tuberculin purified protein derivative (PPD) versus measles, mumps, and rubella (MMR) vaccine in treatment of molluscum contagiosum: a comparative study

 

MMR group

N = 15

PPD group

N = 15

Saline group

N = 15

Test of significance

Within group significance

Duration of disease (months)

4 (2–6)

3 (2–6)

4 (2–6)

KW

P1 = 0.226

P = 0.446

P2 = 0.8066

 

P3 = 0.367

Number of lesions

11 (6–16)

10 (6–17)

8 (6–12)

KW

P1 = 0.492

P = 0.051

P2 = 0.06

 

P3 = 0.081

Site

 Trunk

4 (26.7)

4 (26.7)

5 (33.3)

χ2 = 11.35

 

 Leg

0

2 (13.3)

2 (13.3)

P = 0.499

P1 = 0.306

 Face & neck

9 (60)

8 (53.3)

5 (33.3)

 

P2 = 0.375

 Elbow

0

0

1 (6.7)

 

P3 = 0.785

 Arm

1 (6.7)

1 (6.7)

2 (13.3)

  

 Abdomen

1 (6.7)

0

0

  
  1. KW, Kruskal Wallis test; χ2, Chi-Square test; P1, difference between MMR & PPD group; P2, difference between MMR & Saline group; P3, difference between PPD & Saline group, within group significance was done by Mann Whitney U test.
Back to article page